ZURICH (Reuters) – Germany’s CureVac filed in Switzerland for a rolling review of its COVID-19 vaccine candidate, the Swiss drugs regulator Swissmedic said on Monday, as yet another maker of...

(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody therapies with emergency use authorization in the United States, according...

JOHANNESBURG (Reuters) – South Africa has suspended the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal health agencies...

NEW DELHI (Reuters) – India’s second wave of coronavirus infections continued to swell as it reported a record 115,736 new cases on Wednesday, a 13-fold increase in just over two months and...

NEW DELHI (Reuters) – India reported a record rise in COVID-19 infections on Monday, becoming the second country after the United States to post more than 100,000 new cases in a day, as politicians...

(Reuters) – Data was withheld from World Health Organization investigators who travelled to China to research the origins of the coronavirus epidemic, WHO Director-General Tedros Adhanom Ghebreyesus...

PARIS (Reuters) – France will not let hospitals be in a situation where they have to choose which patients to treat, amid a third wave of the coronavirus pandemic, Health Minister Olivier Veran told...

BERLIN (Reuters) – Germany’s health minister warned on Friday there was not enough vaccine in Europe to contain the COVID-19 third wave, as the country sought to get its rollout back on track...

LONDON (Reuters) – Confidence in the safety of AstraZeneca’s COVID-19 vaccine has taken a big hit in Spain, Germany, France and Italy as reports of rare blood clots have been linked to it and...

COPENHAGEN (Reuters) – Denmark said on Saturday that one person had died and another fell seriously ill with blood clots and cerebral haemorrhage after receiving the AstraZeneca COVID-19 vaccination. The...